vs

Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and OHIO VALLEY BANC CORP (OVBC). Click either name above to swap in a different company.

OHIO VALLEY BANC CORP is the larger business by last-quarter revenue ($16.2M vs $13.3M, roughly 1.2× OCULAR THERAPEUTIX, INC). OHIO VALLEY BANC CORP runs the higher net margin — 24.4% vs -488.0%, a 512.4% gap on every dollar of revenue. On growth, OHIO VALLEY BANC CORP posted the faster year-over-year revenue change (-4.6% vs -22.4%). OHIO VALLEY BANC CORP produced more free cash flow last quarter ($17.0M vs $-57.1M). Over the past eight quarters, OHIO VALLEY BANC CORP's revenue compounded faster (4.3% CAGR vs -5.3%).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

Valley National Bank of Arizona was a bank based in Phoenix, Arizona, founded in 1900 and acquired by Bank One in 1992. The bank was one of Arizona's leading financial institutions during the 20th century and the last major independent bank in Arizona at the time of its acquisition.

OCUL vs OVBC — Head-to-Head

Bigger by revenue
OVBC
OVBC
1.2× larger
OVBC
$16.2M
$13.3M
OCUL
Growing faster (revenue YoY)
OVBC
OVBC
+17.8% gap
OVBC
-4.6%
-22.4%
OCUL
Higher net margin
OVBC
OVBC
512.4% more per $
OVBC
24.4%
-488.0%
OCUL
More free cash flow
OVBC
OVBC
$74.1M more FCF
OVBC
$17.0M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
OVBC
OVBC
Annualised
OVBC
4.3%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCUL
OCUL
OVBC
OVBC
Revenue
$13.3M
$16.2M
Net Profit
$-64.7M
$4.0M
Gross Margin
88.0%
Operating Margin
-526.5%
30.7%
Net Margin
-488.0%
24.4%
Revenue YoY
-22.4%
-4.6%
Net Profit YoY
-33.6%
57.3%
EPS (diluted)
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCUL
OCUL
OVBC
OVBC
Q4 25
$13.3M
$16.2M
Q3 25
$14.5M
$16.3M
Q2 25
$13.5M
$17.4M
Q1 25
$10.7M
$16.8M
Q4 24
$17.1M
$17.0M
Q3 24
$15.4M
$15.4M
Q2 24
$16.4M
$14.7M
Q1 24
$14.8M
$14.9M
Net Profit
OCUL
OCUL
OVBC
OVBC
Q4 25
$-64.7M
$4.0M
Q3 25
$-69.4M
$3.0M
Q2 25
$-67.8M
$4.2M
Q1 25
$-64.1M
$4.4M
Q4 24
$-48.4M
$2.5M
Q3 24
$-36.5M
$2.7M
Q2 24
$-43.8M
$3.0M
Q1 24
$-64.8M
$2.8M
Gross Margin
OCUL
OCUL
OVBC
OVBC
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
OCUL
OCUL
OVBC
OVBC
Q4 25
-526.5%
30.7%
Q3 25
-472.3%
22.9%
Q2 25
-502.6%
29.8%
Q1 25
-597.5%
33.1%
Q4 24
-296.1%
18.1%
Q3 24
-298.2%
21.3%
Q2 24
-265.1%
24.7%
Q1 24
-214.0%
22.8%
Net Margin
OCUL
OCUL
OVBC
OVBC
Q4 25
-488.0%
24.4%
Q3 25
-477.3%
18.5%
Q2 25
-503.9%
24.2%
Q1 25
-598.7%
26.2%
Q4 24
-283.3%
14.8%
Q3 24
-236.6%
17.6%
Q2 24
-266.3%
20.3%
Q1 24
-438.9%
18.8%
EPS (diluted)
OCUL
OCUL
OVBC
OVBC
Q4 25
$-0.27
Q3 25
$-0.38
Q2 25
$-0.39
Q1 25
$-0.38
Q4 24
$-0.25
Q3 24
$-0.22
Q2 24
$-0.26
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCUL
OCUL
OVBC
OVBC
Cash + ST InvestmentsLiquidity on hand
$737.1M
$45.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$654.3M
$170.3M
Total Assets
$808.1M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCUL
OCUL
OVBC
OVBC
Q4 25
$737.1M
$45.9M
Q3 25
$344.8M
$89.3M
Q2 25
$391.1M
$54.6M
Q1 25
$349.7M
$120.6M
Q4 24
$392.1M
$83.1M
Q3 24
$427.2M
$82.2M
Q2 24
$459.7M
$107.7M
Q1 24
$482.9M
$129.1M
Stockholders' Equity
OCUL
OCUL
OVBC
OVBC
Q4 25
$654.3M
$170.3M
Q3 25
$258.2M
$164.4M
Q2 25
$305.9M
$160.8M
Q1 25
$265.9M
$155.7M
Q4 24
$315.3M
$150.3M
Q3 24
$352.0M
$152.2M
Q2 24
$377.7M
$145.8M
Q1 24
$408.0M
$145.8M
Total Assets
OCUL
OCUL
OVBC
OVBC
Q4 25
$808.1M
$1.6B
Q3 25
$410.9M
$1.6B
Q2 25
$451.3M
$1.5B
Q1 25
$405.9M
$1.5B
Q4 24
$457.9M
$1.5B
Q3 24
$490.4M
$1.5B
Q2 24
$517.1M
$1.4B
Q1 24
$538.9M
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCUL
OCUL
OVBC
OVBC
Operating Cash FlowLast quarter
$-54.2M
$18.1M
Free Cash FlowOCF − Capex
$-57.1M
$17.0M
FCF MarginFCF / Revenue
-430.9%
105.2%
Capex IntensityCapex / Revenue
21.4%
6.4%
Cash ConversionOCF / Net Profit
4.57×
TTM Free Cash FlowTrailing 4 quarters
$-216.9M
$26.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCUL
OCUL
OVBC
OVBC
Q4 25
$-54.2M
$18.1M
Q3 25
$-50.7M
$5.3M
Q2 25
$-55.2M
$4.5M
Q1 25
$-44.7M
$496.0K
Q4 24
$-39.4M
$13.1M
Q3 24
$-36.6M
$5.6M
Q2 24
$-24.8M
$4.2M
Q1 24
$-33.9M
$928.0K
Free Cash Flow
OCUL
OCUL
OVBC
OVBC
Q4 25
$-57.1M
$17.0M
Q3 25
$-56.7M
$5.0M
Q2 25
$-56.5M
$4.4M
Q1 25
$-46.6M
$138.0K
Q4 24
$-39.6M
$11.7M
Q3 24
$-36.6M
$5.4M
Q2 24
$-25.5M
$3.9M
Q1 24
$-34.1M
$234.0K
FCF Margin
OCUL
OCUL
OVBC
OVBC
Q4 25
-430.9%
105.2%
Q3 25
-390.0%
30.4%
Q2 25
-419.7%
25.1%
Q1 25
-435.6%
0.8%
Q4 24
-232.0%
68.7%
Q3 24
-237.6%
35.1%
Q2 24
-155.4%
26.3%
Q1 24
-231.1%
1.6%
Capex Intensity
OCUL
OCUL
OVBC
OVBC
Q4 25
21.4%
6.4%
Q3 25
41.2%
2.1%
Q2 25
9.3%
0.6%
Q1 25
18.1%
2.1%
Q4 24
1.2%
8.4%
Q3 24
0.6%
1.2%
Q2 24
4.5%
2.2%
Q1 24
1.7%
4.7%
Cash Conversion
OCUL
OCUL
OVBC
OVBC
Q4 25
4.57×
Q3 25
1.75×
Q2 25
1.06×
Q1 25
0.11×
Q4 24
5.21×
Q3 24
2.06×
Q2 24
1.41×
Q1 24
0.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons